{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:26Z","timestamp":1790835626274,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Childhood Arthritis and Rheumatology Research Alliance"},{"name":"Arthritis Foundation, and Scleroderma Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pcl.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T19:23:41Z","timestamp":1532028221000},"page":"757-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Scleroderma in Children and Adolescents"],"prefix":"10.1016","volume":"65","author":[{"given":"Suzanne C.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pcl.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jdermsci.2017.12.005","article-title":"Systemic sclerosis complicated with localized scleroderma-like lesions induced by Kobner phenomenon","volume":"89","author":"Saigusa","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.pcl.2018.04.002_bib2","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmstead County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib3","first-page":"1004","article-title":"Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease","volume":"33","author":"Scalapino","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10067-006-0483-z","article-title":"Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia","volume":"2007","author":"Misra","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.pcl.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphoea follows Blaschko's lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology"},{"issue":"suppl 10","key":"10.1016\/j.pcl.2018.04.002_bib9","first-page":"S787","article-title":"Description of the localized scleroderma subgroup of the CARRAnet","volume":"63","author":"Wu","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib10","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","article-title":"Systemic sclerosis in childhood. Clinical and immunologic features of 153 patients in an international database","volume":"54","author":"Martini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2018.04.002_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/acr.23547","article-title":"Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis","author":"Stevens","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcl.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrrheum.2011.148","article-title":"Challenges in the diagnosis and treatment of juvenile systemic sclerosis","volume":"7","author":"Rabinovich","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pcl.2005.02.001","article-title":"Scleroderma in children","volume":"52","author":"Zulian","year":"2005","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.pcl.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.38853","article-title":"Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort","volume":"66","author":"Condie","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","volume":"14","author":"Kreuter","year":"2016","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.pcl.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3899\/jrheum.100001","article-title":"Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort","volume":"37","author":"Foeldvari","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.pcl.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/ker521","article-title":"Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK","volume":"51","author":"Hawley","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pcl.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 10","key":"10.1016\/j.pcl.2018.04.002_bib24","article-title":"Description of the juvenile localized scleroderma subgroup of the Childhood Arthritis and Rheumatology Research (CARRA) registry","volume":"67","author":"Wu","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.002_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","article-title":"A\u00a0new computerized method for the assessment of skin lesions in localized scleroderma","volume":"46","author":"Zulian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2018.04.002_bib27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.002_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","article-title":"Activity assessment in morphea using color Doppler ultrasound","volume":"65","author":"Wortsman","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/acr.20407","article-title":"Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcl.2018.04.002_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.11102136","article-title":"Localized scleroderma: MR findings and clinical features","volume":"260","author":"Schanz","year":"2011","journal-title":"Radiology"},{"issue":"Suppl 10","key":"10.1016\/j.pcl.2018.04.002_bib31","first-page":"2453","article-title":"Development of a clinical disease activity measure for juvenile localized scleroderma","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.002_bib32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.002_bib33","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.pcl.2018.04.002_bib34","article-title":"Extracutaneous involvement is common in juvenile localized scleroderma and associated with a higher level of perceived disease impact [abstract]","volume":"69","author":"Li","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib35","first-page":"703017","article-title":"Chronologic presentation of a severe case of progressive hemifacial atrophy (Parry-Romberg syndrome) with the loss of an eye","volume":"2014","author":"Kaya","year":"2014","journal-title":"Case Rep Otolaryngol"},{"key":"10.1016\/j.pcl.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma. A case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.002_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1534734607308731","article-title":"Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma","volume":"6","author":"Wollina","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.pcl.2018.04.002_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2006.04.052","article-title":"Congenital localized scleroderma","volume":"149","author":"Zulian","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.002_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The Pediatric Rheumatology European Society\/American College of Rheumatology\/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pcl.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.002_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/RHU.0000000000000232","article-title":"Systemic sclerosis: commonly asked questions by rheumatologists","volume":"21","author":"Young","year":"2015","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.002_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.pcl.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/rheumatology\/kei106","article-title":"Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score","volume":"45","author":"Foeldvari","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pcl.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-857X(05)70300-8","article-title":"Raynaud's phenomenon","volume":"22","author":"Wigley","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pcl.2018.04.002_bib45","first-page":"200","article-title":"Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring","volume":"34","author":"Pain","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.002_bib46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/acr.22026","article-title":"Nailfold capillaroscopy in pediatrics","volume":"65","author":"Ingegnoli","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcl.2018.04.002_bib47","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.002_bib48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rdc.2015.04.011","article-title":"Musculoskeletal manifestations of systemic sclerosis","volume":"41","author":"Morrisroe","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pcl.2018.04.002_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","article-title":"Pediatric scleroderma: systemic or localized forms","volume":"59","author":"Torok","year":"2012","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.002_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in juvenile systemic sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.pcl.2018.04.002_bib51","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1610-0387.2007.06311.x","article-title":"Differential diagnosis of scleroderma and pseudoscleroderma","volume":"5","author":"Fabri","year":"2007","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.pcl.2018.04.002_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","article-title":"Scleroderma mimics","volume":"14","author":"Nashel","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.pcl.2018.04.002_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features","volume":"55","author":"Kurzinski","year":"2011","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.pcl.2018.04.002_bib54","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2018.04.002_bib55","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/art.38814","article-title":"Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea","volume":"66","author":"Jacobe","year":"2014","journal-title":"Arthitis Rheum"},{"key":"10.1016\/j.pcl.2018.04.002_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.002_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0625.2010.01082.x","article-title":"Scleroderma: from pathophysiology to novel therapeutic approaches","volume":"19","author":"Hunzelmann","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2014.04.009","article-title":"The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the morphea in adults and children cohort IV","volume":"71","author":"Grabell","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199806000-00003","article-title":"Histopathologic differentiation between localized and systemic scleroderma","volume":"20","author":"Torres","year":"1998","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.002_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","article-title":"Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014","volume":"27","author":"Young","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.pcl.2018.04.002_bib61","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.002_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.002_bib63","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1111\/pde.12799","article-title":"Radiologic improvement after early medical intervention in localised facial morphea","volume":"33","author":"Khan","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.002_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3899\/jrheum.090708","article-title":"Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists","volume":"37","author":"Li","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.pcl.2018.04.002_bib65","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A\u00a0long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.pcl.2018.04.002_bib66","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2018.04.002_bib67","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.002_bib68","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib69","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/art.38444","article-title":"A28: description of the juvenile localized scleroderma subgroup of the CARRA registry","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.002_bib70","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/acr.23101","article-title":"Predictors of longitudinal quality of life in juvenile localized scleroderma","volume":"69","author":"Ardalan","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.pcl.2018.04.002_bib71","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/rheumatology\/kes144","article-title":"Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database","volume":"51","author":"Foeldvari","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:20:41Z","timestamp":1758475241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395518300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0031395518300415"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2018.04.002","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma in Children and Adolescents","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}